Close this search box.
    • Small Molecules
      • Discovery
    • Biologics
    • Other Drug Modalities
    • SynVent Integrated Drug Discovery
      • SynVent Integrated Drug Discovery

        SynVent is Syngene’s platform for fully integrated therapeutic discovery and development across large and small molecules. 

    • Industries
    • Emerging Biopharma
      • Emerging Biopharma

        Emerging biopharma work at the forefront of science, often venturing into disease areas where little or no real-world data exists to work with or regulatory frameworks to work within.

    • Dedicated Centers
      • Dedicated Centers

        Our Dedicated Centers offer dedicated multi-disciplinary scientific teams, support personnel, and a tailormade ring-fenced and fire-walled infrastructure as per client specifications to support their  R&D  goals

    • Center for Advanced Protein Studies (CAPS)
      • Center for Advanced Protein Studies (CAPS)

        Centre for Advanced Protein Studies [CAPS] is a state-of-the-art advanced national facility located in the Syngene campus, Bangalore.

  • Careers
Close this search box.

Facility videos

Choose from a variety of resources to get a better understanding of Syngene’s point of view, expertise or approach to drug discovery, development and manufacturing to ensure client success.

Syngene’s Center of Excellence for Oligonucleotides: Early Discovery to cGMP manufacturing services

Our Oligonucleotides facility offers end-to-end services, from early discovery to cGMP manufacturing. Specialty areas include chemically synthesized high-quality modified and non-modified custom oligonucleotide (DNA/RNA); siRNA (single & double-stranded); miRNA (modified and non-modified); antisense oligonucleotides; phosphodiesters and morpholinos; all types of oligo conjugates, and all types of base and custom modifications.

Syngene’s Small Molecule cGMP commercial manufacturing facility

Syngene’s state-of-the-art small molecule cGMP manufacturing facility is USFDA and PMDA-approved. The facility manufactures clinical (early and late-phase) and commercial drug substances (NCEs), advanced intermediates, regulatory starting materials, and selected generic APIs for clients. The facility’s manufacturing output ranges from grams to hundreds of kilograms per batch, with total volumes ranging from 60L to 8000L.

Syngene's high potent API manufacturing facility

Our high potent API facility is designed to handle cytotoxic and cytostatic high-potency compounds with a commitment to safety. It has an occupational exposure limit (OEL) of up to 0.01 µg/m over 8 hours and is categorized within Band 4/5. The cGMP facility is positioned to meet the stringent requirements of the regulated market. Additionally, it boasts an integrated cGMP facility dedicated to manufacturing non-potent compounds.

Syngene Quality Control Biologics Lab

Our Quality Control Biologics lab uses the latest technology and equipment for testing biologics products, with a strong focus on digitalization and automation. Our stringent quality control procedures and standards ensure the accuracy and reliability of results. Further, we are one of the pioneers of real-wear-assisted reality glasses for collaborative technology transfer and hosting remote inspections in alignment with FDA guidelines.

Syngene API manufacturing facility, Mangalore

Our GMP-certified, API manufacturing facility in Mangalore is a state-of-the-art, multi-product, multi-client, contract facility. Spread across 46 acres, it is designed to support all large-scale API and advanced intermediate manufacturing requirements of our clients.

Syngene Large Molecule Bioanalytical Laboratory

Explore Syngene’s Large Molecule Bioanalytical Laboratory, which is India’s premier GLP- certified and GCLP-compliant lab. It specializes in immunogenicity and pharmacokinetic (PK) analysis of biologics and biosimilars.

Syngene Discovery Chemistry facility, Hyderabad

Explore our new 52,000 sq. ft., state-of-the-art R&D center in Genome valley, Hyderabad. Focused on Discovery Chemistry services, we are excited to be expanding our facilities to assist more clients accelerate their research programs.

Syngene’s early-stage Chemistry Process Research lab for drug discovery

Watch this video on our early-stage Chemistry Process Research lab for drug discovery that supports pre-clinical studies, medicinal chemistry, and integrated project requirements (from mg to kg scale).

Syngene’s Sterile Fill-Finish facility for Clinical Supplies – Biologics & Small Molecules

In this video, Syngene scientist Saurabh Sahu takes you through the capabilities and features of our integrated Sterile Fill-Finish facility for clinical supplies of Biologics and Small Molecules, as well as, products that are sensitive to light, heat and oxygen.

Syngene COVID-19 Testing Center using qRT-PCR

Want to know, how Syngene conducts RT-PCR testing at its COVID-19 Testing laboratory? Approved by Indian Council of Medical Research (ICMR), this lab has tested more than 100000+ samples so far.

Your browser does not support this function.

To download, Please share your details

This Website uses Cookies

We use cookies to improve your experience on our site and show you information relevant to your requirements.

To find out more, read our Privacy Policy and Cookies Policy.

To view or email, Please share your details view

To download, Please share your details